{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:56Z","timestamp":1759336376728},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1096,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pacific Psychiatry"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1111\/j.1758-5872.2012.00232.x","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T09:53:08Z","timestamp":1346406788000},"page":"164-167","source":"Crossref","is-referenced-by-count":8,"title":["One-year follow-up study of psychotic patients treated with blonanserin: A case series"],"prefix":"10.1111","volume":"5","author":[{"given":"Sakae","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Psychiatry, Department of Psychiatry, School of Medicine; Nihon University; Tokyo; Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Psychiatry, School of Medicine; Nihon University; Tokyo; Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Psychiatry, School of Medicine; Nihon University; Tokyo; Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,31]]},"reference":[{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0009|appy232-cit-0001","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (4th Edn, Text Revision)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0001|appy232-cit-0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11202620-000000000-00000","article-title":"Blonanserin: a review of its use in the management of schizophrenia","volume":"24","author":"Deeks","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0002|appy232-cit-0003","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics: differential risk and clinical implications","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"10.1111\/j.1758-5872.2012.00232.x-BIB0003|appy232-cit-0004","first-page":"32","article-title":"Prolactin-related and metabolic adverse effects of atypical antipsychotic agents","volume":"69","author":"Henderson","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0005|appy232-cit-0005","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0004|appy232-cit-0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0006|appy232-cit-0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eurpsy.2005.09.009","article-title":"Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia","volume":"21","author":"Martin","year":"2006","journal-title":"Eur Psychiatry"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0007|appy232-cit-0008","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"Os","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1758-5872.2012.00232.x-BIB0008|appy232-cit-0009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WNF.0b013e3181dcda50","article-title":"Efficacy and tolerability of blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial","volume":"33","author":"Yang","year":"2010","journal-title":"Clin Neuropharmacol"}],"container-title":["Asia-Pacific Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1758-5872.2012.00232.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1758-5872.2012.00232.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T21:39:08Z","timestamp":1612474748000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1758-5872.2012.00232.x"}},"subtitle":["Blonanserin treatment follow-up"],"short-title":[],"issued":{"date-parts":[[2012,8,31]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1758-5872.2012.00232.x","relation":{},"ISSN":["1758-5864"],"issn-type":[{"value":"1758-5864","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,31]]}}}